This revealed that while ARF3 mRNA levels are widely altered in tumor versus normal tissue, the directionality of ARF3 mRNA alternation in tumors is dependent on tissue type and that ARF3 mRNA expression is not a consistent indicator of clinical characteristics (Fig. S5, A and B). This evidence concerns the gene ARF3 and neoplasm.